OncoSec Medical Inc (ONCSQ)

[jDiz_]

OncoSec Granted New Patent from China

OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse and NeoPulse technologies to treat solid tumor cancers, received a new Method of Use and Device patent (Patent Application No. 200780014313.0, "Method and Device for Treating Microscopic Residual Tumors Remaining in Tissues Following Surgical Resection") for the OncoSec Medical System (OMS) electroporation device platform from the State Intellectual Property Office of the People's Republic of China. The issuance of this patent has the potential to expand OncoSec's commercial opportunities for minimally invasive and surgical procedures to treat solid tumors in a very large market such as China.